[go: up one dir, main page]

AU8182187A - Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof - Google Patents

Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof

Info

Publication number
AU8182187A
AU8182187A AU81821/87A AU8182187A AU8182187A AU 8182187 A AU8182187 A AU 8182187A AU 81821/87 A AU81821/87 A AU 81821/87A AU 8182187 A AU8182187 A AU 8182187A AU 8182187 A AU8182187 A AU 8182187A
Authority
AU
Australia
Prior art keywords
derivatives
diphenylpiperidine
medicaments
novel
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81821/87A
Inventor
Jacques Dreux
Jean-Pierre Nallet
Serge Petit
Jacqueline Winicki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Laboratoires Hoechst S A
Laboratoires Hoechst SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Hoechst S A, Laboratoires Hoechst SA filed Critical Laboratoires Hoechst S A
Publication of AU8182187A publication Critical patent/AU8182187A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU81821/87A 1986-11-27 1987-11-26 Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof Abandoned AU8182187A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3640475 1986-11-27
DE19863640475 DE3640475A1 (en) 1986-11-27 1986-11-27 MEDICINAL PRODUCTS BASED ON DERIVATIVES OF 3,4-DIPHENYLPIPERIDINE, THE USE OF THE DERIVATIVES AS A MEDICINAL PRODUCT AND NEW 3,4-DIPHENYLPIPERIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
AU8182187A true AU8182187A (en) 1988-06-02

Family

ID=6314857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81821/87A Abandoned AU8182187A (en) 1986-11-27 1987-11-26 Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof

Country Status (9)

Country Link
EP (1) EP0273199A3 (en)
JP (1) JPS63141965A (en)
KR (1) KR880006194A (en)
AU (1) AU8182187A (en)
DE (1) DE3640475A1 (en)
DK (1) DK621187A (en)
IE (1) IE873212L (en)
PT (1) PT86211B (en)
ZA (1) ZA878881B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
HRP20040550A2 (en) * 2001-11-19 2006-11-30 Elan Pharmaceuticals 3,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines and piperazines
JP4667366B2 (en) 2003-04-04 2011-04-13 ハー・ルンドベック・アクチエゼルスカベット 4- (2-Phenylsulfanyl-phenyl) -piperidine derivatives as serotonin reuptake inhibitors
AU2004303461B2 (en) 2003-12-23 2011-04-28 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
AR052308A1 (en) 2004-07-16 2007-03-14 Lundbeck & Co As H DERIVATIVES OF 2- (1H-INDOLILSULFANIL) -ARILAMINE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (en) 2005-06-17 2007-06-20 Lundbeck & Co As H DERIVATIVES OF BENZO (B) FURANO AND BENZO (B) THIOPHEN, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF THE REINFORCEMENT OF AMINA BOSS NEUTRANTS.

Also Published As

Publication number Publication date
EP0273199A2 (en) 1988-07-06
IE873212L (en) 1988-05-27
DE3640475A1 (en) 1988-06-09
DK621187A (en) 1988-05-28
PT86211B (en) 1990-11-07
DK621187D0 (en) 1987-11-26
JPS63141965A (en) 1988-06-14
PT86211A (en) 1987-12-01
KR880006194A (en) 1988-07-22
EP0273199A3 (en) 1988-07-20
ZA878881B (en) 1988-10-26

Similar Documents

Publication Publication Date Title
AU7171787A (en) 1-hydroxy-2-pyridones, a process for their preparation, and medicaments which contain them, and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
AU587648B2 (en) Process for the preparation of (2,2)- paracyclophane
HUT47103A (en) Process for producing 1,4-benzoxazine derivatives and pharmaceutical compositions comprising the same
DE3662104D1 (en) 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments
AU622007B2 (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions
AU578793B2 (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof
AU2653788A (en) Manumycin derivatives, a process for the preparation thereof, and the use thereof
AU1446688A (en) New 2-acylpyrrolidine derivatives, a process for the preparation thereof, agents containing them, and their use
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
AU8198987A (en) Carbamoylimidazole derivatives, a process for their preparation, and their use as fungicides
EP0264744A3 (en) Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives.
AU601787B2 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids, new intermediate products, processes for their preparation and their use as medicaments
AU8182187A (en) Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof
AU6879987A (en) Insulin derivatives, a process for their preparation, and their use
AU8306987A (en) Novel carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments
AU2193688A (en) N-(substituted alkylidene)-1,2,3,4-tetrahydro-9-acridinamines, a process for their preparation and their use as medicaments
ZA878659B (en) 12-halogenated forskolin derivatives,intermediates and a process for the preparation thereof and their use as medicaments
AU590431B2 (en) A method for the preparation of 2,4-diamino-3-oxy-6- piperidyl-pyrimidine
AU2975089A (en) Novel compounds, process for the preparation thereof and uses thereof
AU609980B2 (en) Hydrazinocarbonyloxylabdanes, a process for their preparation and their use as medicaments
AU7652487A (en) Process for the preparation of 2,4-diamino-5-benzylpyrimidines
AU589100B2 (en) Process for the preparation of N,N'-tetrathiodimorpholine
AU7466987A (en) Cytorhodin S derivatives, a process for their preparation and their use as medicaments
AU7762687A (en) Urdamycin G and derivatives thereof, a process for their preparation, and their use
AU624309B2 (en) New selenophen derivatives, a preparation process of the same and therapeutical compositions containing them